Ipca Laboratories Limited
IPCALAB
Classement en actions
#3414
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Prix de l'action
$20.02
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$5.08B
Changement (1 jour)
-1.65%
Changement (1 an)
38.46%
Pays
IN
Échange Ipca Laboratories Limited (IPCALAB)
Catégorie
Healthcare
Nombre d'actions en circulation pour Ipca Laboratories Limited (IPCALAB)
Nombre d'actions en circulation au June 2026: 253.70M
Selon les derniers rapports financiers et le cours de l'action de Ipca Laboratories Limited, le nombre actuel d'actions en circulation est de 253.70M. À la fin de March 2024, l'entreprise avait 253.70M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Ipca Laboratories Limited (IPCALAB) de 2005 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 253.70M | 0.00% |
| 2025 | 253.70M | 0.00% |
| 2024 | 253.70M | 0.00% |
| 2023 | 253.70M | 0.00% |
| 2022 | 253.70M | 0.17% |
| 2021 | 253.28M | 0.16% |
| 2020 | 252.89M | 0.09% |
| 2019 | 252.65M | 0.09% |
| 2018 | 252.42M | 0.01% |
| 2017 | 252.40M | -0.01% |
| 2016 | 252.41M | 0.01% |
| 2015 | 252.40M | 0.00% |
| 2014 | 252.40M | 0.03% |
| 2013 | 252.32M | 0.08% |
| 2012 | 252.11M | 0.52% |
| 2011 | 250.81M | 0.41% |
| 2010 | 249.79M | -0.51% |
| 2009 | 251.07M | 0.31% |
| 2008 | 250.31M | 0.12% |
| 2007 | 250.00M | 0.00% |
| 2006 | 250.00M | 0.00% |
| 2005 | 250.00M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 845.72% |
IN
|
